To give informed consent in research, persons must be mentally capable of understanding the study, risks, and benefits. An objective screening tool may assess cognitive capacity better than brief conversations or clinician input. The purpose is to explore the validity of the Mental Alternations Test (MAT) to assess the cognitive capacity of older (ages 50 years +) HIV+ persons (N = 81). Descriptive correlational quantitative method was used. About 12% of the sample was cognitively impaired. Contrary to expectations, primary language was the only variable with a significant relationship with the MAT (r = -.22, p = .02); there were no significant relationships between the MAT and age, education, alcohol, smoking, injection drug use, street or mind-altering drug use, physical functional status, depressive symptoms, comorbidities, or being diagnosed with AIDS. Our findings suggest caution in using the MAT as an instrument for assessing cognitive impairment in a linguistically diverse population.
Arguelles, T., & Loewenstein, D. (1997). Research says si to development of culturally appropriate cognitive assessment tools. Generations , 21(1), 30-31.
2.
Billick, S., Siedenburg, E., Burgert, W., & Bruni-Solhkhah, S. (2001). Validation of the Mental Alternation Test with the Mini-Mental Examination in geriatric psychiatric inpatients and normal controls. Comprehensive Psychiatry, 42, 202-205.
3.
Bowling, A. (2001). Measuring disease: A review of disease-specific quality of life measurement scales. Buckingham: Open University Press.
4.
Burns, N., & Grove, S. (2005). The practice of nursing research: Conduct, critique, & utilization. St. Louis: Elsevier & Saunders.
5.
Corless, I., Bakken, S., Nicholas, P., Holzemer, W., McGibbon, C., Inouye, J., et al. (2000). Predictors of perception of cognitive functioning in HIV/AIDS. Journal of the Association of Nurses in AIDS Care, 11(3), 19-26.
6.
Department of Health and Human Services. ( 2005). Basic HHS policy for protection of human research subjects . Retrieved August 20, 2006, from http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.htm#46.116
7.
DeVellis, R. (2003). Scale development: Theory and applications. Thousand Oaks, CA: Sage.
8.
Germino, B. (2002). Research in chronic illness. In I. Lubkin & P. Larsen (Eds.), Chronic illness: Impact and interventions (pp. 385-405). Boston, MA: Jones and Bartlett.
9.
Goodkin, K., Wilkie, F., Concha, M., Hinkin, C., Symes, S., Baldewicz, T., et al. (2001). Aging and neuro-AIDS conditions and the changing spectrum of HIV-1 associated morbidity and mortality. Journal ofClinical Epidemiology, 54, S35-S43.
10.
Horton, A., & Roberts, C. (2003). Demographic effects on the Trail Making Test in a drug abuse treatment sample. Archives ofClinical Neuropsychology , 18(1), 49-56.
11.
Jones, B., Teng, E., Folstein, M., & Harrison, K. (1993). A new bedside test of cognition for patients with HIV infection. Archives ofInternal Medicine, 119, 1001-1004.
12.
Lavelle-Jones, C., Byrne, D.J., Rice, P., & Cuschieri, A. (1993). Factors affecting quality of informed consent . British Medical Journal, 306, 885-890.
13.
Lu, L., & Bigler, E. (2002). Normative data on Trail Making Test for neurologically normal Chinese-speaking adults. Applied Neuropsychology, 9(4), 219-225.
14.
New York City Department of Health and Mental Hygiene. (2007). HIV epidemiology & field services semiannual report covering January 1, 2006, to June 30, 2005. Retrieved September 24, 2007, from http://www.nyc.gov/html/doh/downloads/pdf/dires/dires-2007-report-semi1.pdf
15.
Nokes, K., & Nwakeze, P. (2007). Assessing cognitive capacity for participation in a research study. Clinical Nursing Research, 16(4), 336-349.
16.
Oller, J., Kim, K., & Choe, Y. (2000). Testing verbal (language) and non-verbal abilities in language minorities: A socio-educational problem in historical perspective . Language Testing, 17(3), 341-360.
17.
Parsons, T., Tucker, K., Hall, C., Robertson, W., Eron, J., Fried, M., et al. (2006). Neurocognitive functioning and HAART in HIV and hepatitis C virus co-infection. AIDS, 20(12), 1591-1595.
18.
Radloff, L. (1977). The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1, 385-401.
19.
Salib, E. (2002). Mental Alternations Test (MAT): A rapid and valid screening tool for dementia in primary care. International Journal of Geriatric Psychiatry, 17, 1157-1161.
20.
Teng, E. (1995). The Mental Alternations Test (MAT). The Clinical Neuropsychologist, 9, 287.
21.
University of California, Los Angeles. (2006 ). CES-D. Retrieved August 24, 2006, from http://chipts.ucla.edu/assessment/Assessment_Instruments/Assessment_files_new/assess_cesd.htm
22.
University of Washington. (2006). Ethics in medicine: Informed consent. Retrieved August 20, 2006, from http://depts.washington.edu/bioethx/topics/consent.html#ques5
23.
Valcour, V., & Paul, R. (2006). HIV & dementia in older adults: Should we be concerned?Clinical Infectious Diseases, 42, 1449-1454.
24.
Valcour, V., & Sacktor, N. (2002). HIV-associated dementia and aging. Journal of Mental Health andAging, 8(4), 295-306.
25.
Wood, S., Friedland, B., & McGrory, C.E. (2001). Informed consent: From good intentions to sound practices: Report of a seminar. NY: Population Council , 1-43.
